Allotex

Boston, MA · Founded 2014 · Privately Held (backing)

Operator of an ophthalmic biologics and device company intended for the treatment of presbyopia, hyperopia and myopia. Allotex is based in Boston, MA and was founded in 2014. It was valued at $358 million at its early-stage round in Mar 2018, the last priced event on record. It has raised $46.8 million across 1 recorded round; the latest was a $16.7 million early-stage round in Feb 2018.

PMV mark · valuation
$358.0M
Oct 2026
Priced at
its early-stage round
Mar 2018
Total raised
$46.8M
Last round
Early Stage VC
Feb 2018
How much has Allotex raised?
$46.8Macross 1 recorded rounds · Feb 2018 – Feb 2018

Most recently, Allotex raised $16.7M in its Early Stage VC (Feb 2018).

Free account
More of Allotex with a free account
  • ·Watch Allotex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Allotex round by round

1 rounds
Feb 2018Early Stage VC$16.7MSEC filing▮
2 investors participated

How much has Allotex raised?

Allotex has raised $46.8 million in total; 1 of its rounds is on record. The largest on record was a $16.7 million early-stage round in Feb 2018.

Allotex has filed 1 Form D with the SEC, most recently in Mar 2018 ($16.7 million sold to 2 investors).

Allotex investors

6 investors are on record for Allotex, including Supernova Invest, Panakes Partners, Exor and Junson Capital. The early-stage round in Feb 2018 drew 2 investors.

For fundraisers
Raising for a company like Allotex?

6 investors have backed Allotex.

See all 6 investors →

Frequently asked about Allotex

How much has Allotex raised?
Allotex has raised $46.8M in total across 1 recorded funding rounds.
When was Allotex's last funding round?
Allotex's most recent recorded round was Early Stage VC in Feb 2018, raising $16.7M.
Allotex Funding Rounds & Investors — $46.8M Raised | Premier Alternatives